Detalhe da pesquisa
1.
Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study.
BMC Health Serv Res
; 16(1): 424, 2016 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553193
2.
Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
Diabetologia
; 58(12): 2753-64, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409458
3.
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.
Blood
; 115(6): 1145-55, 2010 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20007541
4.
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients.
Diabetes Metab Res Rev
; 27(8): 925-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22069286
5.
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
N Engl J Med
; 352(25): 2598-608, 2005 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15972866
6.
Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.
J Clin Endocrinol Metab
; 100(2): 551-60, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25405499
7.
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
J Clin Pharmacol
; 50(11): 1238-48, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20147616
8.
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients.
Transplantation
; 87(3): 402-7, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19202446
9.
Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.
Proc Natl Acad Sci U S A
; 103(46): 17444-9, 2006 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17090674